u/viktor_laurent
Contributes reviews on supplier material. Based in Cork.
member · joined 15 Jun 2025
Comments — page 5 of 5
comment on stalled for 11 weeks at 2.5mg and I refuse to panic this time in c/orforglipron · 2 points · 1 year ago
cite ATTAIN/ACHIEVE arms specifically
comment on [Results] 21 weeks on 2.4mg, full numbers, ask me anything boring in c/retatrutide · 3 points · 1 year ago
retatrutide is not approved anywhere for human use, posts must not read as instructions
comment on what changed for me between week 60 and week 8 in c/orforglipron · 17 points · 1 year ago
oral non-peptide agonist is small molecule, no food restrictions
comment on anyone else notice moderation kicking in around week 4 in c/meta · 17 points · 1 year ago
I love that this community will spend 40 comments on a detail. That pedantry is why the numbers here matter.
comment on New Zealand is the most under-discussed thing in c/insurancefights in c/glp1aus · 17 points · 1 year ago
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
comment on [Results] 57 weeks, 15kg, and BPC-157 was the hard part in c/bpc157 · -38 points · 1 year ago
Titration speed is a side-effect dial far more than an efficacy dial.
comment on [Discussion] insulin resistance is doing more work than we give it credit for in c/glp1women · 45 points · 1 year ago
The confident tone is doing a lot of work that the evidence is not.
comment on triple agonist is the most under-discussed thing in c/glp1uk in c/retatrutide · 1 points · 1 year ago
TRIUMPH data is phase 2, not phase 3, smaller n and shorter
comment on [Question] New Zealand — has anyone got a straight answer on non-peptide in c/orforglipron · 9 points · 1 year ago
availability speculation must be flaired Speculation
comment on anyone else notice retatrutide kicking in around week 94 in c/retatrutide · 38 points · 1 year ago
research use only, handling and analysis, not protocols
comment on the compounding question that gets asked weekly, answered properly in c/glp1aus · 275 points · 1 year ago
AU or NZ?
comment on ATTAIN: the version I wish someone had shown me in week 1 in c/orforglipron · 1 points · 2 years ago
Strongly agree. The supply impact would be huge.
comment on triple agonist — 22 things I got wrong before I got it right in c/retatrutide · 92 points · 2 years ago
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
comment on [Meta] the resistance training rule is doing its job and people should stop complaining in c/glp1muscle · 11 points · 2 years ago
body-composition claims need a method
comment on week 71 check-in — 7kg down, reflux manageable, one thing confusing me in c/bpc157 · 145 points · 2 years ago
rodent data must be labelled as rodent data
comment on disclosure — 18 things I got wrong before I got it right in c/meta · 36 points · 2 years ago
comment on the Australia question that gets asked weekly, answered properly in c/glp1aus · -24 points · 2 years ago
My version of this: I was so worried about the injection that I put it off for eleven days. The injection is the easiest part.
comment on week 56 check-in — 46kg down, early fullness manageable, one thing confusing me in c/retatrutide · 116 points · 2 years ago
retatrutide is not approved anywhere for human use, posts must not read as instructions
comment on [Question] Sweden — has anyone got a straight answer on pentadecapeptide in c/bpc157 · 1 points · 2 years ago
Yeah, rodent data does not scale to humans.
comment on anyone else notice phase 2 kicking in around week 30 in c/retatrutide · 176 points · 2 years ago
research use only, handling and analysis, not protocols